Jane Buchan insider trades
Open-market stock purchases and sales by Jane Buchan, Director at Immix Biopharma, Inc, from SEC Form 4 filings since Nov 16, 2023.
Open-market stock purchases and sales by Jane Buchan, Director at Immix Biopharma, Inc, from SEC Form 4 filings since Nov 16, 2023.